Last reviewed · How we verify

switching to different class of antidepressant

Korea University · Phase 1 active Small molecule Quality 0/100

switching to different class of antidepressant is a Small molecule drug developed by Korea University. It is currently in Phase 1 development. Also known as: escitalopram, fluoxetine, paroxetine, sertraline.

At a glance

Generic nameswitching to different class of antidepressant
Also known asescitalopram, fluoxetine, paroxetine, sertraline, bupropion XL
SponsorKorea University
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about switching to different class of antidepressant

What is switching to different class of antidepressant?

switching to different class of antidepressant is a Small molecule drug developed by Korea University.

Who makes switching to different class of antidepressant?

switching to different class of antidepressant is developed by Korea University (see full Korea University pipeline at /company/korea-university).

Is switching to different class of antidepressant also known as anything else?

switching to different class of antidepressant is also known as escitalopram, fluoxetine, paroxetine, sertraline, bupropion XL.

What development phase is switching to different class of antidepressant in?

switching to different class of antidepressant is in Phase 1.

Related